FDA Grants Approval for First Skin Cancer Drug
The U.S. Food and Drug Administration approved the first drug to treat basal cell carcinoma, the most common form of skin cancer, on Monday.
The U.S. Food and Drug Administration approved the first drug to treat basal cell carcinoma, the most common form of skin cancer, on Monday.
Scientists in San Diego are developing new vaccines that will potentially cure addictions, allowing cigarette and drug abusers to kick their habits with a simple injection.
Dr. Kim D. Janda, a Scripps Research Institute professor, is one of the leading experts, having made addiction vaccines his main priority for the past 25 years. “We view this as an alternative or better way for some people,” he tells The New York Times in reference to rehab programs.